The different associations of serum gamma-glutamyl transferase and alanine aminotransferase with insulin secretion, β-cell function, and insulin resistance in non-obese Japanese.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • Subject Terms:
    • Abstract:
      The present study investigated the associations of serum gamma-glutamyl transferase (GGT), a marker of fatty liver and oxidative stress, and ALT/AST, a marker of fatty liver, with percentage trunk fat and postload glucose, insulin resistance, and β-cell function in middle-aged Japanese individuals, whose BMI averaged < 23.0 kg/m 2 . Pancreatic β-cell function was assessed using the disposition index calculated by a product of the insulinogenic index (IGI) and Matsuda insulin sensitivity index, a biomarker of early-phase glucose-stimulated insulin secretion and whole-body insulin sensitivity, respectively. Multivariate linear regression analyses revealed that the disposition index was associated inversely with GGT independently of percentage trunk fat, homeostasis model assessment insulin resistance (HOMA-IR), a marker of insulin resistance, and Matsuda index. When IGI was included instead of the disposition index, IGI (inversely) and HOMA-IR were associated with GGT independently of percentage trunk fat and Matsuda index. When the area under the glucose concentration curve (AUCg) during an oral glucose tolerance test was included instead of the disposition index, AUCg and HOMA-IR emerged as independent determinants of GGT. ALT/AST was associated with HOMA-IR alone. Results suggest a different pathophysiologic basis between GGT and ALT/AST in predicting diabetic risk in non-obese Japanese.
      (© 2024. The Author(s).)
    • References:
      Del Prato, S. et al. Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management. Int. J. Clin. Pract. 64, 295–304 (2010). (PMID: 10.1111/j.1742-1241.2009.02227.x20456169)
      Tanaka, S., Honda, M., Wu, B. & Kazumi, T. Clinical features of normal weight Japanese patients with type 2 diabetes who had formerly been obese. J. Atheroscler. Thromb. 18, 115–121 (2011). (PMID: 10.5551/jat.592621071881)
      Yabe, D., Seino, Y., Fukushima, M. & Seino, S. β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians. Curr. Diab. Rep. 15, 602. https://doi.org/10.1007/s11892-015-0602-9 (2015). (PMID: 10.1007/s11892-015-0602-925944304)
      Tsuboi, A. et al. Higher circulating orosomucoid, an acute-phase protein, and reduced glucose-induced insulin secretion in middle-aged Japanese people with prediabetes. BMJ Open Diabetes Res. Care 8, e001392. https://doi.org/10.1136/bmjdrc-2020-001392 (2020). (PMID: 10.1136/bmjdrc-2020-001392331158177594205)
      Tsuboi, A. et al. Higher circulating orosomucoid and lower early-phase insulin secretion in midlife Japanese with slower glucose disposal during oral glucose tolerance tests. Diabetol. Int. 11, 27–32 (2019). (PMID: 10.1007/s13340-019-00398-6319500016942068)
      Smith, U. & Kahn, B. B. Adipose tissue regulates insulin sensitivity: Role of adipogenesis, de novo lipogenesis and novel lipids. J. Intern. Med. 280, 465–475 (2016). (PMID: 10.1111/joim.12540276998985218584)
      Azzu, V. et al. Adipose tissue-liver cross talk in the control of whole-body metabolism: Implications in nonalcoholic fatty liver disease. Gastroenterology. 158, 1899–1912 (2020). (PMID: 10.1053/j.gastro.2019.12.05432061598)
      Azuma, K. et al. Higher liver fat content among Japanese in Japan compared with non-Hispanic whites in the United States. Metabolism 58, 1200–1207 (2009). (PMID: 10.1016/j.metabol.2009.03.021194280362714590)
      Nannipieri, M. et al. Liver enzymes, the metabolic syndrome, and incident diabetes: The Mexico City diabetes study. Diabetes Care 28, 1757–1762 (2005). (PMID: 10.2337/diacare.28.7.175715983331)
      Fraser, A. et al. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: The British Women’s Heart and Health Study and meta-analysis. Diabetes Care. 32, 741–750 (2009). (PMID: 10.2337/dc08-1870191314662660465)
      Nguyen, Q. M. et al. Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: The Bogalusa Heart Study. Diabetes Care 34, 2603–2607 (2011). (PMID: 10.2337/dc11-0919219537983220830)
      Schneider, A. L. et al. Liver enzymes, race, gender and diabetes risk: The Atherosclerosis Risk in Communities (ARIC) Study. Diabet Med. 30, 926–933 (2013). (PMID: 10.1111/dme.12187235101983715563)
      Ko, S. H. et al. Increased liver markers are associated with higher risk of type 2 diabetes. World J Gastroenterol. 21, 7478–7487 (2015). (PMID: 10.3748/wjg.v21.i24.7478261399934481442)
      Doi, Y. et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: The Hisayama study. Obesity (Silver Spring) 15, 1841–1850 (2007). (PMID: 10.1038/oby.2007.21817636103)
      Sato, K. K. et al. Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: The Kansai Healthcare Study. Diabetes Care 31, 1230–1236 (2008). (PMID: 10.2337/dc07-218418316395)
      Kaneko, K. et al. Association of gamma-glutamyl transferase and alanine aminotransferase with type 2 diabetes mellitus incidence in middle-aged Japanese men: 12-year follow up. J. Diabetes Investig. 10, 837–845 (2019). (PMID: 10.1111/jdi.1293030204299)
      Choi, S. H., Kim, B. T., Shin, J. & Kim, K. N. Combined effect of serum alanine aminotransferase and gamma-glutamyltransferase on incidence of diabetes mellitus: A longitudinal study. Medicine (Baltimore) 99, e18963. https://doi.org/10.1097/MD.0000000000018963 (2020). (PMID: 10.1097/MD.000000000001896332176028)
      Hua, S. et al. Association of liver enzymes with incident diabetes in US Hispanic/Latino adults. Diabet Med. 38, e14522. https://doi.org/10.1111/dme.14522 (2021). (PMID: 10.1111/dme.1452233434318)
      Brennan, P. N., Dillon, J. F. & Tapper, E. B. Gamma-Glutamyl Transferase (γ-GT)—An old dog with new tricks?. Liver Int. 42, 9–15 (2022). (PMID: 10.1111/liv.1509934775657)
      Oprescu, A. I. et al. Free fatty acid-induced reduction in glucose-stimulated insulin secretion: Evidence for a role of oxidative stress in vitro and in vivo. Diabetes 56, 2927–2937 (2007). (PMID: 10.2337/db07-007517717282)
      Lytrivi, M., Castell, A. L., Poitout, V. & Cnop, M. Recent insights into mechanisms of β-cell lipo- and glucolipotoxicity in type 2 diabetes. J. Mol. Biol. 432, 1514–1534 (2020). (PMID: 10.1016/j.jmb.2019.09.01631628942)
      Minato-Inokawa, S. et al. Associations of alanine aminotransferase/aspartate aminotransferase with insulin resistance and β-cell function in women. Sci. Rep. 13, 7853. https://doi.org/10.1038/s41598-023-35001-1 (2023). (PMID: 10.1038/s41598-023-35001-13718885910185667)
      Wu, B. et al. Different associations of trunk and lower-body fat mass distribution with cardiometabolic risk factors between healthy middle-aged men and women. Int. J. Endocrinol. 2018, 1289485. https://doi.org/10.1155/2018/1289485 (2018). (PMID: 10.1155/2018/1289485295315275817354)
      Tanaka, S. et al. Associations of lower-body fat mass with favorable profile of lipoproteins and adipokines in healthy, slim women in early adulthood. J. Atheroscler. Thromb. 18, 365–372 (2011). (PMID: 10.5551/jat.722921233589)
      Kitaoka, K. et al. Increased adipose and muscle insulin sensitivity without changes in serum adiponectin in young female collegiate athletes. Metab. Syndr. Relat. Disord. 15, 246–251 (2017). (PMID: 10.1089/met.2017.0011283183845485219)
      Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419 (1985). (PMID: 10.1007/BF002808833899825)
      Matsuda, M. & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462–1470 (1999). (PMID: 10.2337/diacare.22.9.146210480510)
      Tura, A., Kautzky-Willer, A. & Pacini, G. Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res. Clin. Pract. 72, 298–301 (2006). (PMID: 10.1016/j.diabres.2005.10.00516325298)
      Ohn, J. H. et al. 10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: A community-based prospective cohort study. Lancet Diabetes Endocrinol. 4, 27–34 (2016). (PMID: 10.1016/S2213-8587(15)00336-826577716)
      American Diabetes Association 2. Diabetes Care. 41, S13-S27 (2018).
      Tsuboi, A. et al. Association of serum orosomucoid with 30-min plasma glucose and glucose excursion during oral glucose tolerance tests in non-obese young Japanese women. BMJ Open Diabetes Res. Care 6, e000508. https://doi.org/10.1136/bmjdrc-2018-000508 (2018). (PMID: 10.1136/bmjdrc-2018-000508297321645931285)
      Vella, C. A. et al. Associations of insulin resistance with cardiovascular risk factors and inflammatory cytokines in normal-weight Hispanic women. Diabetes Care 36, 1377–1383 (2013). (PMID: 10.2337/dc12-1550232753563631836)
      Honda, M. et al. Birth weight was associated positively with gluteofemoral fat mass and inversely with 2-h postglucose insulin concentrations, a marker of insulin resistance, in young normal-weight Japanese women. Diabetol Int. 13, 375–380 (2021). (PMID: 10.1007/s13340-021-00543-0354638588980117)
      Honda, M. et al. Reduced gluteofemoral (subcutaneous) fat mass in young Japanese women with family history of type 2 diabetes: An exploratory analysis. Sci. Rep. 12, 12579. https://doi.org/10.1038/s41598-022-16890-0 (2022). (PMID: 10.1038/s41598-022-16890-0358692809307820)
      Wang, L. et al. New evidence for an association between liver enzymes and pancreatic islet β-cell dysfunction in young obese patients. Endocrine 44, 688–695 (2013). (PMID: 10.1007/s12020-013-9937-723549778)
      Smith, U. Abdominal obesity: a marker of ectopic fat accumulation. J. Clin. Invest. 125, 1790–1792 (2015). (PMID: 10.1172/JCI81507259326764463217)
    • Contributed Indexing:
      Keywords: ALT/AST glucose-stimulated insulin secretion; Gamma-glutamyl transferase; Insulin resistance; Japanese people; β-cell function
    • Accession Number:
      EC 2.3.2.2 (gamma-Glutamyltransferase)
      EC 2.6.1.2 (Alanine Transaminase)
      0 (Insulin)
      0 (Biomarkers)
      0 (Blood Glucose)
    • Publication Date:
      Date Created: 20240820 Date Completed: 20240820 Latest Revision: 20240823
    • Publication Date:
      20240826
    • Accession Number:
      PMC11336068
    • Accession Number:
      10.1038/s41598-024-70396-5
    • Accession Number:
      39164380